{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T14:46:33Z","timestamp":1794667593707,"version":"4.9.1"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82373838"],"award-info":[{"award-number":["82373838"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Microsyst Nanoeng"],"DOI":"10.1038\/s41378-025-01116-w","type":"journal-article","created":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T04:26:43Z","timestamp":1770092803000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Micro pharmacokinetics-pharmacodynamics monitoring of anti-Parkinson\u2019s disease drugs using a microphysiological BBB-brain organ-on-a-chip"],"prefix":"10.1038","volume":"12","author":[{"given":"Yu","family":"Zhong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren-Yi","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi-Yang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian-Qian","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ai-Lin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,3]]},"reference":[{"key":"1116_CR1","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/S1474-4422(25)00033-X","volume":"24","author":"M Tinazzi","year":"2025","unstructured":"Tinazzi, M. et al. Advances in diagnosis, classification, and management of pain in Parkinson\u2019s disease. Lancet Neurol. 24, 331\u2013347 (2025).","journal-title":"Lancet Neurol."},{"key":"1116_CR2","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202412548","volume":"12","author":"H Kim","year":"2025","unstructured":"Kim, H. et al. Parkinson\u2019s disease modeling using directly converted 3D Induced dopaminergic neuron organoids and assembloids. Adv. Sci. 12, e2412548 (2025).","journal-title":"Adv. Sci."},{"key":"1116_CR3","doi-asserted-by":"publisher","first-page":"3306","DOI":"10.1093\/brain\/awae177","volume":"147","author":"C Roodveldt","year":"2024","unstructured":"Roodveldt, C. et al. The immune system in Parkinson\u2019s disease: what we know so far. Brain 147, 3306\u20133324 (2024).","journal-title":"Brain"},{"key":"1116_CR4","doi-asserted-by":"publisher","first-page":"13804","DOI":"10.1073\/pnas.0702753104","volume":"104","author":"KS Rommelfanger","year":"2007","unstructured":"Rommelfanger, K. S. et al. Norepinephrine loss produces more profound motor deficits than MPTP treatment in mice. Proc. Natl. Acad. Sci. USA 104, 13804\u201313809 (2007).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"1116_CR5","doi-asserted-by":"publisher","first-page":"351","DOI":"10.2165\/00023210-200013050-00005","volume":"13","author":"AM Bonnet","year":"2000","unstructured":"Bonnet, A. M. Involvement of non-dopaminergic pathways in Parkinson\u2019s disease. CNS Drugs 13, 351\u2013364 (2000).","journal-title":"CNS Drugs"},{"key":"1116_CR6","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak, H. et al. Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol. Aging 24, 197\u2013211 (2003).","journal-title":"Neurobiol. Aging"},{"key":"1116_CR7","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1093\/brain\/awh445","volume":"128","author":"P Remy","year":"2005","unstructured":"Remy, P., Doder, M., Lees, A., Turjanski, N. & Brooks, D. Depression in Parkinson\u2019s disease: Loss of dopamine and noradrenaline innervation in the limbic system. Brain 128, 1314\u20131322 (2005).","journal-title":"Brain"},{"key":"1116_CR8","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/S0140-6736(23)01429-0","volume":"403","author":"T Foltynie","year":"2024","unstructured":"Foltynie, T. et al. Medical, surgical, and physical treatments for Parkinson\u2019s disease. Lancet 403, 305\u2013324 (2024).","journal-title":"Lancet"},{"key":"1116_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12987-020-00230-3","volume":"17","author":"H Kadry","year":"2020","unstructured":"Kadry, H., Noorani, B. & Cucullo, L. A blood-brain barrier overview on structure, function, impairment, and biomarkers of integrity. Fluids Barriers CNS 17, 1\u201324 (2020).","journal-title":"Fluids Barriers CNS"},{"key":"1116_CR10","doi-asserted-by":"publisher","first-page":"e2303180","DOI":"10.1002\/adhm.202303180","volume":"13","author":"AR Mulay","year":"2024","unstructured":"Mulay, A. R., Hwang, J. & Kim, D. H. Microphysiological blood-brain barrier systems for disease modeling and drug development. Adv. Healthc. Mater. 13, e2303180 (2024).","journal-title":"Adv. Healthc. Mater."},{"key":"1116_CR11","doi-asserted-by":"publisher","first-page":"9261","DOI":"10.3390\/ijms24119261","volume":"24","author":"SB Al Rihani","year":"2023","unstructured":"Al Rihani, S. B., Batarseh, Y. S. & Kaddoumi, A. The blood-brain barrier in health and disease. Int. J. Mol. Sci. 24, 9261 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"1116_CR12","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.jconrel.2023.04.020","volume":"358","author":"D Qi","year":"2023","unstructured":"Qi, D., Lin, H., Hu, B. & Wei, Y. A review on in vitro model of the blood-brain barrier (BBB) based on hCMEC\/D3 cells. J. Control. Rel. 358, 78\u201397 (2023).","journal-title":"J. Control. Rel."},{"key":"1116_CR13","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1038\/s41551-024-01250-2","volume":"9","author":"JG Shamul","year":"2025","unstructured":"Shamul, J. G. et al. Meta-analysis of the make-up and properties of in vitro models of the healthy and diseased blood-brain barrier. Nat. Biomed. Eng. 9, 566\u2013598 (2025).","journal-title":"Nat. Biomed. Eng."},{"key":"1116_CR14","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1602\/neurorx.2.1.3","volume":"2","author":"WM Pardridge","year":"2005","unstructured":"Pardridge, W. M. The blood-brain barrier: Bottleneck in brain drug development. NeuroRx. 2, 3\u201314 (2005).","journal-title":"NeuroRx"},{"key":"1116_CR15","doi-asserted-by":"publisher","first-page":"4499","DOI":"10.1158\/0008-5472.CAN-09-4264","volume":"70","author":"AM Carcaboso","year":"2010","unstructured":"Carcaboso, A. M. et al. Tyrosine kinase inhibitor gefitinib enhances topotecan penetration of gliomas. Cancer Res. 70, 4499\u20134508 (2010).","journal-title":"Cancer Res."},{"key":"1116_CR16","doi-asserted-by":"publisher","first-page":"335","DOI":"10.3109\/03602532.2011.560607","volume":"43","author":"F Zhou","year":"2011","unstructured":"Zhou, F. et al. Toward a new age of cellular pharmacokinetics in drug discovery. Drug Metab. Rev. 43, 335\u2013345 (2011).","journal-title":"Drug Metab. Rev."},{"key":"1116_CR17","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1517\/17460441.2015.1067196","volume":"10","author":"G Vauquelin","year":"2015","unstructured":"Vauquelin, G. On the \u2018micro\u2019-pharmacodynamic and pharmacokinetic mechanisms that contribute to long-lasting drug action. Expert Opin. Drug Discov. 10, 1085\u20131098 (2015).","journal-title":"Expert Opin. Drug Discov."},{"key":"1116_CR18","first-page":"525","volume":"31","author":"L Bai","year":"2023","unstructured":"Bai, L. et al. AI-enabled organoids: construction, analysis, and application. Bioact. Mater. 31, 525\u2013548 (2023).","journal-title":"Bioact. Mater."},{"key":"1116_CR19","doi-asserted-by":"publisher","first-page":"13384","DOI":"10.3390\/molecules200713384","volume":"20","author":"LG Ferreira","year":"2015","unstructured":"Ferreira, L. G., Dos Santos, R. N., Oliva, G. & Andricopulo, A. D. Molecular docking and structure-based drug design strategies. Molecules 20, 13384\u201313421 (2015).","journal-title":"Molecules"},{"key":"1116_CR20","doi-asserted-by":"publisher","first-page":"2205752","DOI":"10.1002\/advs.202205752","volume":"10","author":"W Wei","year":"2023","unstructured":"Wei, W., Cardes, F., Hierlemann, A. & Modena, M. M. 3D in vitro blood-brain-barrier model for investigating barrier insults. Adv. Sci. 10, 2205752 (2023).","journal-title":"Adv. Sci."},{"key":"1116_CR21","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1038\/nrd4627","volume":"14","author":"CA MacRae","year":"2015","unstructured":"MacRae, C. A. & Peterson, R. T. Zebrafish as tools for drug discovery. Nat. Rev. Drug Discov. 14, 721\u2013731 (2015).","journal-title":"Nat. Rev. Drug Discov."},{"key":"1116_CR22","doi-asserted-by":"publisher","first-page":"114816","DOI":"10.1016\/j.addr.2023.114816","volume":"196","author":"A P\u00e9rez-L\u00f3pez","year":"2023","unstructured":"P\u00e9rez-L\u00f3pez, A., Torres-Su\u00e1rez, A. I., Mart\u00edn-Sabroso, C. & Aparicio-Blanco, J. An overview of in vitro 3D models of the blood-brain barrier as a tool to predict the in vivo permeability of nanomedicines. Adv. Drug Deliv. Rev. 196, 114816 (2023).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"1116_CR23","doi-asserted-by":"publisher","first-page":"160","DOI":"10.3390\/biom10010160","volume":"10","author":"O Kosz\u0142a","year":"2020","unstructured":"Kosz\u0142a, O., Targowska-Duda, K. M., K\u0119dzierska, E. & Kaczor, A. A. In vitro and in vivo models for the investigation of potential drugs against schizophrenia. Biomolecules 10, 160 (2020).","journal-title":"Biomolecules"},{"key":"1116_CR24","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1038\/nbt.2989","volume":"32","author":"SN Bhatia","year":"2014","unstructured":"Bhatia, S. N. & Ingber, D. E. Microfluidic organs-on-chips. Nat. Biotechnol. 32, 760\u2013772 (2014).","journal-title":"Nat. Biotechnol."},{"key":"1116_CR25","doi-asserted-by":"publisher","first-page":"102728","DOI":"10.1016\/j.arr.2025.102728","volume":"107","author":"C Song","year":"2025","unstructured":"Song, C., Yang, J. & Gu, Z. Latest developments of microphysiological systems (MPS) in aging-related and geriatric diseases research: a review. Ageing Res. Rev. 107, 102728 (2025).","journal-title":"Ageing Res. Rev."},{"key":"1116_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-10588-0","volume":"10","author":"TE Park","year":"2019","unstructured":"Park, T. E. et al. Hypoxia-enhanced blood-brain barrier chip recapitulates human barrier function and shuttling of drugs and antibodies. Nat. Commun. 10, 2621 (2019).","journal-title":"Nat. Commun."},{"key":"1116_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13896-7","volume":"11","author":"SI Ahn","year":"2020","unstructured":"Ahn, S. I. et al. Microengineered human blood-brain barrier platform for understanding nanoparticle transport mechanisms. Nat. Commun. 11, 175 (2020).","journal-title":"Nat. Commun."},{"key":"1116_CR28","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1038\/s41551-023-01054-w","volume":"8","author":"P Wang","year":"2024","unstructured":"Wang, P. et al. Blood-brain barrier injury and neuroinflammation induced by SARS-CoV-2 in a lung-brain microphysiological system. Nat. Biomed. Eng. 8, 1053\u20131068 (2024).","journal-title":"Nat. Biomed. Eng."},{"key":"1116_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-26066-5","volume":"12","author":"I Pediaditakis","year":"2021","unstructured":"Pediaditakis, I. et al. Modeling alpha-synuclein pathology in a human brain-chip to assess blood-brain barrier disruption. Nat. Commun. 12, 5907 (2021).","journal-title":"Nat. Commun."},{"key":"1116_CR30","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/s41551-019-0498-9","volume":"4","author":"A Herland","year":"2020","unstructured":"Herland, A. et al. Quantitative prediction of human pharmacokinetic responses to drugs via fluidically coupled vascularized organ chips. Nat. Biomed. Eng. 4, 421\u2013436 (2020).","journal-title":"Nat. Biomed. Eng."},{"key":"1116_CR31","doi-asserted-by":"publisher","first-page":"2564","DOI":"10.1038\/s41596-021-00511-7","volume":"16","author":"J Aleman","year":"2021","unstructured":"Aleman, J., Kilic, T., Mille, L. S., Shin, S. R. & Zhang, Y. S. Microfluidic integration of regeneratable electrochemical affinity-based biosensors for continual monitoring of organ-on-a-chip devices. Nat. Protoc. 16, 2564\u20132593 (2021).","journal-title":"Nat. Protoc."},{"key":"1116_CR32","doi-asserted-by":"publisher","first-page":"115271","DOI":"10.1016\/j.bios.2023.115271","volume":"231","author":"AG Monteduro","year":"2023","unstructured":"Monteduro, A. G. et al. Organs-on-chips technologies - A guide from disease models to opportunities for drug development. Biosens. Bioelectron. 231, 115271 (2023).","journal-title":"Biosens. Bioelectron."},{"key":"1116_CR33","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1186\/s12951-024-02720-0","volume":"22","author":"RO Rodrigues","year":"2024","unstructured":"Rodrigues, R. O., Shin, S. R. & Ba\u00f1obre-L\u00f3pez, M. Brain-on-a-chip: An emerging platform for studying the nanotechnology-biology interface for neurodegenerative disorders. J. Nanobiotechnol. 22, 573 (2024).","journal-title":"J. Nanobiotechnol."},{"key":"1116_CR34","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1016\/j.tibtech.2020.03.001","volume":"38","author":"HC Ates","year":"2020","unstructured":"Ates, H. C. et al. On-site therapeutic drug monitoring. Trends Biotechnol. 38, 1262\u20131277 (2020).","journal-title":"Trends Biotechnol."},{"key":"1116_CR35","doi-asserted-by":"publisher","first-page":"e4623","DOI":"10.1002\/bmc.4623","volume":"34","author":"M van Nuland","year":"2020","unstructured":"van Nuland, M., Rosing, H., Schellens, J. H. & Beijnen, J. H. Bioanalytical LC-MS\/MS validation of therapeutic drug monitoring assays in oncology. Biomed. Chromatogr. 34, e4623 (2020).","journal-title":"Biomed. Chromatogr."},{"key":"1116_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.talanta.2023.124996","volume":"266","author":"Z Fang","year":"2023","unstructured":"Fang, Z., Zhang, H., Guo, J. & Guo, J. Overview of therapeutic drug monitoring and clinical practice. Talanta 266, 124996 (2023).","journal-title":"Talanta"},{"key":"1116_CR37","doi-asserted-by":"publisher","first-page":"114125","DOI":"10.1016\/j.bios.2022.114125","volume":"206","author":"JH Qu","year":"2022","unstructured":"Qu, J. H. et al. Point-of-care therapeutic drug monitoring of adalimumab by integrating a FO-SPR biosensor in a self-powered microfluidic cartridge. Biosens. Bioelectron. 206, 114125 (2022).","journal-title":"Biosens. Bioelectron."},{"key":"1116_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.talanta.2023.124981","volume":"266","author":"S Evangelista","year":"2024","unstructured":"Evangelista, S. et al. High throughput LC-MS\/MS method for steroid hormone analysis in rat liver and plasma-unraveling methodological challenges. Talanta 266, 124981 (2024).","journal-title":"Talanta"},{"key":"1116_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.chroma.2022.462952","volume":"1670","author":"ME Mostafa","year":"2022","unstructured":"Mostafa, M. E., Grinias, J. P. & Edwards, J. L. Evaluation of nanospray capillary LC-MS performance for metabolomic analysis in complex biological matrices. J. Chromatogr. A 1670, 462952 (2022).","journal-title":"J. Chromatogr. A"},{"key":"1116_CR40","doi-asserted-by":"publisher","first-page":"2679","DOI":"10.1021\/acssensors.0c01318","volume":"5","author":"H Teymourian","year":"2020","unstructured":"Teymourian, H. et al. Wearable electrochemical sensors for the monitoring and screening of drugs. ACS Sens 5, 2679\u20132700 (2020).","journal-title":"ACS Sens"},{"key":"1116_CR41","doi-asserted-by":"publisher","first-page":"19017","DOI":"10.1073\/pnas.2009979117","volume":"117","author":"S Lin","year":"2020","unstructured":"Lin, S. et al. Noninvasive wearable electroactive pharmaceutical monitoring for personalized therapeutics. Proc. Natl. Acad. Sci. USA 117, 19017\u201319025 (2020).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"1116_CR42","doi-asserted-by":"publisher","first-page":"15123","DOI":"10.1021\/acs.analchem.9b03826","volume":"91","author":"XK Yang","year":"2019","unstructured":"Yang, X. K. et al. A\u03b21\u201342 oligomers induced a short-term increase of glutamate release prior to its depletion as measured by amperometry on single varicosities. Anal. Chem. 91, 15123\u201315129 (2019).","journal-title":"Anal. Chem."},{"key":"1116_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.talanta.2025.127588","volume":"287","author":"Y Zhong","year":"2025","unstructured":"Zhong, Y., Liu, M. M., Cao, X., Lei, Y. & Liu, A. L. In situ biosensing for cell viability and drug evaluation in 3D extracellular matrix cultures: applications in cytoprotection of oxidative stress injury. Talanta 287, 127588 (2025).","journal-title":"Talanta"},{"key":"1116_CR44","first-page":"552","volume":"12","author":"YM Shanbhag","year":"2022","unstructured":"Shanbhag, Y. M. et al. Direct and sensitive electrochemical evaluation of pramipexole using graphitic carbon nitride (gCN) sensor. Biosens. Basel 12, 552 (2022).","journal-title":"Biosens. Basel"},{"key":"1116_CR45","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/j.msec.2017.02.072","volume":"75","author":"S Amirighadi","year":"2017","unstructured":"Amirighadi, S., Raoof, J. B., Chekin, F. & Ojani, R. A sensitive voltammetric detection of pramipexole based on 1,1,3,3-tetramethyldisilazanecarbon nanotube modified electrode. Mat. Sci. Eng. C. Mater. 75, 784\u2013790 (2017).","journal-title":"Mat. Sci. Eng. C. Mater."},{"key":"1116_CR46","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/S1474-4422(10)70106-X","volume":"9","author":"P Barone","year":"2010","unstructured":"Barone, P. et al. Pramipexole for the treatment of depressive symptoms in patients with Parkinson\u2019s disease: a randomised, double-blind, placebo-controlled trial. Lancet Neurol. 9, 573\u2013580 (2010).","journal-title":"Lancet Neurol."},{"key":"1116_CR47","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/npp.2008.114","volume":"34","author":"O Chernoloz","year":"2009","unstructured":"Chernoloz, O., El Mansari, M. & Blier, P. Sustained administration of pramipexole modifies the spontaneous firing of dopamine, norepinephrine, and serotonin neurons in the rat brain. Neuropsychopharmacology 34, 651\u2013661 (2009).","journal-title":"Neuropsychopharmacology"},{"key":"1116_CR48","doi-asserted-by":"publisher","first-page":"dmm045021","DOI":"10.1242\/dmm.045021","volume":"13","author":"M Salman","year":"2020","unstructured":"Salman, M., Tabassum, H. & Parvez, S. Nrf2\/HO-1 mediates the neuroprotective effects of pramipexole by attenuating oxidative damage and mitochondrial perturbation after traumatic brain injury in rats. Dis. Model. Mech. 13, dmm045021 (2020).","journal-title":"Dis. Model. Mech."},{"key":"1116_CR49","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1007\/s12640-022-00495-6","volume":"40","author":"J Huang","year":"2022","unstructured":"Huang, J. et al. Pramipexole protects against traumatic brain injury-induced blood-brain barrier (BBB) dysfunction. Neurotox. Res. 40, 1020\u20131028 (2022).","journal-title":"Neurotox. Res."},{"key":"1116_CR50","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202201401","volume":"18","author":"S Kawakita","year":"2022","unstructured":"Kawakita, S. et al. Organ-on-a-chip models of the blood-brain barrier: recent advances and future prospects. Small 18, e2201401 (2022).","journal-title":"Small"},{"key":"1116_CR51","doi-asserted-by":"publisher","DOI":"10.1186\/s12989-023-00556-4","volume":"20","author":"Y Huang","year":"2023","unstructured":"Huang, Y. et al. Polystyrene nanoplastic exposure induces excessive mitophagy by activating AMPK\/ULK1 pathway in differentiated SH-SY5Y cells and dopaminergic neurons in vivo. Part. Fibre Toxicol. 20, 44 (2023).","journal-title":"Part. Fibre Toxicol."},{"key":"1116_CR52","doi-asserted-by":"publisher","first-page":"20","DOI":"10.31083\/j.jin2201020","volume":"22","author":"OC Ioghen","year":"2023","unstructured":"Ioghen, O. C., Ceafalan, L. C. & Popescu, B. O. SH-SY5Y cell line in vitro models for Parkinson disease research-old practice for new trends. J. Integr. Neurosci. 22, 20 (2023).","journal-title":"J. Integr. Neurosci."},{"key":"1116_CR53","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.expneurol.2010.03.028","volume":"224","author":"AHV Schapira","year":"2010","unstructured":"Schapira, A. H. V. Complex I: inhibitors, inhibition and neurodegeneration. Exp. Neurol. 224, 331\u2013335 (2010).","journal-title":"Exp. Neurol."},{"key":"1116_CR54","first-page":"1086","volume":"123","author":"HR Xie","year":"2010","unstructured":"Xie, H. R., Hu, L. S. & Li, G. Y. SH-SY5Y human neuroblastoma cell line: In vitro cell model of dopaminergic neurons in Parkinson\u2019s disease. Chin. Med. J. Peking. 123, 1086\u20131092 (2010).","journal-title":"Chin. Med. J. Peking."},{"key":"1116_CR55","doi-asserted-by":"publisher","first-page":"111967","DOI":"10.1016\/j.fct.2021.111967","volume":"149","author":"RF Sim\u00f5es","year":"2021","unstructured":"Sim\u00f5es, R. F. et al. Refinement of a differentiation protocol using neuroblastoma SH-SY5Y cells for use in neurotoxicology research. Food Chem. Toxicol. 149, 111967 (2021).","journal-title":"Food Chem. Toxicol."},{"key":"1116_CR56","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1007\/s00604-024-06250-2","volume":"191","author":"Y Zhong","year":"2024","unstructured":"Zhong, Y. et al. In vitro drug screening models derived from different PC12 cell lines for exploring Parkinson\u2019s disease based on electrochemical signals of catecholamine neurotransmitters. Microchim. Acta 191, 170 (2024).","journal-title":"Microchim. Acta"},{"key":"1116_CR57","doi-asserted-by":"publisher","first-page":"111686","DOI":"10.1016\/j.bios.2019.111686","volume":"144","author":"MM Liu","year":"2019","unstructured":"Liu, M. M. et al. Paper-based 3D culture device integrated with electrochemical sensor for the on-line cell viability evaluation of amyloid-beta peptide induced damage in PC12 cells. Biosens. Bioelectron. 144, 111686 (2019).","journal-title":"Biosens. Bioelectron."},{"key":"1116_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.aca.2021.339409","volume":"1194","author":"MM Liu","year":"2022","unstructured":"Liu, M. M. et al. Electrochemical monitoring the effect of drug intervention on PC12 cell damage model cultured on paper-PLA 3D printed device. Anal. Chim. Acta. 1194, 339409 (2022).","journal-title":"Anal. Chim. Acta"},{"key":"1116_CR59","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.bios.2014.02.017","volume":"57","author":"X Liu","year":"2014","unstructured":"Liu, X. et al. Overoxidized polyimidazole\/graphene oxide copolymer modified electrode for the simultaneous determination of ascorbic acid, dopamine, uric acid, guanine and adenine. Biosens. Bioelectron. 57, 232\u2013238 (2014).","journal-title":"Biosens. Bioelectron."},{"key":"1116_CR60","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.trac.2017.10.009","volume":"97","author":"R Jain","year":"2017","unstructured":"Jain, R., Jadon, N. & Pawaiya, A. Polypyrrole based next generation electrochemical sensors and biosensors: a review. TrAC Trend Anal. Chem. 97, 363\u2013373 (2017).","journal-title":"TrAC Trend Anal. Chem."},{"key":"1116_CR61","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.bios.2014.06.044","volume":"62","author":"YS Gao","year":"2014","unstructured":"Gao, Y. S. et al. Overoxidized polypyrrole\/graphene nanocomposite with good electrochemical performance as novel electrode material for the detection of adenine and guanine. Biosens. Bioelectron. 62, 261\u2013267 (2014).","journal-title":"Biosens. Bioelectron."},{"key":"1116_CR62","doi-asserted-by":"publisher","first-page":"116529","DOI":"10.1016\/j.jelechem.2022.116529","volume":"919","author":"A Berni","year":"2022","unstructured":"Berni, A., Lahcen, A. A., Salama, K. N. & Amine, A. 3D-porous laser-scribed graphene decorated with overoxidized polypyrrole as an electrochemical sensing platform for dopamine. Electroanal. Chem. 919, 116529 (2022).","journal-title":"Electroanal. Chem."},{"key":"1116_CR63","doi-asserted-by":"publisher","first-page":"72","DOI":"10.3390\/molecules28010072","volume":"28","author":"F Ghezzi","year":"2022","unstructured":"Ghezzi, F. et al. Nitrogen-doped carbon quantum dots for biosensing applications: The effect of the thermal treatments on electrochemical and optical properties. Molecules 28, 72 (2022).","journal-title":"Molecules"},{"key":"1116_CR64","doi-asserted-by":"publisher","first-page":"11210","DOI":"10.1021\/acs.langmuir.2c01225","volume":"38","author":"S Wu","year":"2022","unstructured":"Wu, S. et al. Influence of nitrogen-doped carbon quantum dots on the electrocatalytic performance of the CoP nanoflower catalyst for OER. Langmuir 38, 11210\u201311218 (2022).","journal-title":"Langmuir"},{"key":"1116_CR65","doi-asserted-by":"publisher","DOI":"10.1002\/cey2.395","volume":"6","author":"Z Cheng","year":"2024","unstructured":"Cheng, Z. et al. Targeted regeneration and upcycling of spent graphite by defect-driven tin nucleation. Carbon Energy 6, e395 (2024).","journal-title":"Carbon Energy"},{"key":"1116_CR66","doi-asserted-by":"publisher","first-page":"2306","DOI":"10.1016\/j.apsb.2020.11.023","volume":"11","author":"L Han","year":"2021","unstructured":"Han, L. & Jiang, C. Evolution of blood-brain barrier in brain diseases and related systemic nanoscale brain-targeting drug delivery strategies. Acta Pharm. Sin. B 11, 2306\u20132325 (2021).","journal-title":"Acta Pharm. Sin. B"},{"key":"1116_CR67","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s40035-024-00430-z","volume":"13","author":"K Lau","year":"2024","unstructured":"Lau, K., Kotzur, R. & Richter, F. Blood-brain barrier alterations and their impact on Parkinson\u2019s disease pathogenesis and therapy. Transl. Neurodegener. 13, 37 (2024).","journal-title":"Transl. Neurodegener."},{"key":"1116_CR68","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-39038-8","volume":"14","author":"A de Rus Jacquet","year":"2023","unstructured":"de Rus Jacquet, A. et al. The contribution of inflammatory astrocytes to BBB impairments in a brain-chip model of Parkinson\u2019s disease. Nat. Commun. 14, 3651 (2023).","journal-title":"Nat. Commun."},{"key":"1116_CR69","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-60148-y","volume":"16","author":"S Gu","year":"2025","unstructured":"Gu, S. et al. Photoelectrochemical biosensor with single atom sites for norepinephrine sensing and brain region synergy in epilepsy. Nat. Commun. 16, 4765 (2025).","journal-title":"Nat. Commun."},{"key":"1116_CR70","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioelechem.2022.108262","volume":"148","author":"S Guilbault","year":"2022","unstructured":"Guilbault, S. et al. Design of optoelectrodes for the remote imaging of cells and in situ electrochemical detection of neurosecretory events. Bioelectrochemistry 148, 108262 (2022).","journal-title":"Bioelectrochemistry"},{"key":"1116_CR71","doi-asserted-by":"publisher","first-page":"117845","DOI":"10.1016\/j.bios.2025.117845","volume":"288","author":"C Song","year":"2025","unstructured":"Song, C. et al. Optical and electrochemical probes-assisted dual-mode nanosensor for ultrasensitive monitoring of serotonin in single cells. Biosens. Bioelectron. 288, 117845 (2025).","journal-title":"Biosens. Bioelectron."},{"key":"1116_CR72","doi-asserted-by":"publisher","first-page":"117375","DOI":"10.1016\/j.bios.2025.117375","volume":"278","author":"R Madhuvilakku","year":"2025","unstructured":"Madhuvilakku, R., Choi, H. J., Jeong, O. C. & Hong, Y. Nanozyme film with dicopper-coordinated amino-ligands: a dual enzyme-mimic for real-time in situ dopamine sensing in human neuroblastoma cells. Biosens. Bioelectron. 278, 117375 (2025).","journal-title":"Biosens. Bioelectron."},{"key":"1116_CR73","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17165-w","volume":"11","author":"D Doi","year":"2020","unstructured":"Doi, D. et al. Pre-clinical study of induced pluripotent stem cell-derived dopaminergic progenitor cells for Parkinson\u2019s disease. Nat. Commun. 11, 3369 (2020).","journal-title":"Nat. Commun."},{"key":"1116_CR74","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.stem.2025.01.006","volume":"32","author":"J Jeon","year":"2025","unstructured":"Jeon, J. et al. Pre-clinical safety and efficacy of human induced pluripotent stem cell-derived products for autologous cell therapy in Parkinson\u2019s disease. Cell Stem Cell 32, 343\u2013360 (2025).","journal-title":"Cell Stem Cell"},{"key":"1116_CR75","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.jneumeth.2004.03.021","volume":"138","author":"ME Hows","year":"2004","unstructured":"Hows, M. E., Lacroix, L., Heidbreder, C., Organ, A. J. & Shah, A. J. High-performance liquid chromatography\/tandem mass spectrometric assay for the simultaneous measurement of dopamine, norepinephrine, 5-hydroxytryptamine and cocaine in biological samples. J. Neurosci. Meth. 138, 123\u2013132 (2004).","journal-title":"J. Neurosci. Meth."},{"key":"1116_CR76","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1093\/chromsci\/48.10.811","volume":"48","author":"M Yadav","year":"2010","unstructured":"Yadav, M. et al. Validated ultra-performance liquid chromatography tandem mass spectrometry method for the determination of pramipexole in human plasma. J. Chromatogr. Sci. 48, 811\u2013818 (2010).","journal-title":"J. Chromatogr. Sci."}],"container-title":["Microsystems &amp; Nanoengineering"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41378-025-01116-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41378-025-01116-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41378-025-01116-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T06:03:02Z","timestamp":1770098582000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41378-025-01116-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,3]]},"references-count":76,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1116"],"URL":"https:\/\/doi.org\/10.1038\/s41378-025-01116-w","relation":{},"ISSN":["2055-7434"],"issn-type":[{"value":"2055-7434","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,3]]},"assertion":[{"value":"4 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study did not involve any experiments on animals or humans. All data used in this study were obtained from publicly available sources or were generated in accordance with ethical guidelines. The study was conducted in compliance with all relevant ethical standards and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"49"}}